» Articles » PMID: 14767764

Bilateral Urinary Calculi After Treatment with a Silicate-containing Milk Thickener

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2004 Feb 10
PMID 14767764
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Nephrocalcinosis and/or urinary calculi are rare in infants. Furosemide treatment during the neonatal period, vitamin D intoxication, hereditary diseases such as hyperoxaluria or distal tubular acidosis are among the most common aetiologies. We report the case of a 6-month-old boy with an extra-hepatic biliary duct atresia treated by the Kasai procedure and a gastro-oesophageal reflux treated with a silicate containing milk thickener (Gelopectose, 5.5% colloidal silicate) since the neonatal period. He did not present any other endogenous risk factor for urinary stone formation (normal urinary calcium/creatinine ratio; normal urinary magnesium excretion). The nephrolithiasis was discovered as the boy presented painful episodes of macroscopic haematuria. Ultrasound examination revealed bilateral nephrocalcinosis and multiple bilateral calculi without infection or urinary obstruction. Infrared spectroscopy revealed silicate as the major component suggesting silicate absorption to be responsible for the described symptoms. After replacement of the silicate-containing agent by a silicate-free milk thickener, the lesions were completely reversible as confirmed by repeated renal ultrasound examinations over a 2-month period.

Conclusion: Silicate-containing milk thickeners can be responsible for urinary calculi and/or nephrocalcinosis.

Citing Articles

Re-evaluation of calcium silicate (E 552), magnesium silicate (E 553a(i)), magnesium trisilicate (E 553a(ii)) and talc (E 553b) as food additives.

Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, Filipic M EFSA J. 2020; 16(8):e05375.

PMID: 32626019 PMC: 7009349. DOI: 10.2903/j.efsa.2018.5375.


Drug-Induced Urolithiasis in Pediatric Patients.

Sighinolfi M, Eissa A, Bevilacqua L, Zoeir A, Ciarlariello S, Morini E Paediatr Drugs. 2019; 21(5):323-344.

PMID: 31541411 DOI: 10.1007/s40272-019-00355-5.


Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Daudon M, Frochot V, Bazin D, Jungers P Drugs. 2017; 78(2):163-201.

PMID: 29264783 DOI: 10.1007/s40265-017-0853-7.


Silicate calculi, a rare cause of kidney stones in children.

Tasdemir M, Fucucuoglu D, Ozman O, Sever L, Onal B, Bilge I Pediatr Nephrol. 2016; 32(2):371-374.

PMID: 27709297 DOI: 10.1007/s00467-016-3504-4.

References
1.
Irisawa C, Suzuki K, Nakagawa H, Sugano O, Kato H, Abe Y . [Silicate urolithiasis: a case report]. Hinyokika Kiyo. 1991; 37(3):267-71. View

2.
Ronnefarth G, Misselwitz J . Nephrocalcinosis in children: a retrospective survey. Members of the Arbeitsgemeinschaft für pädiatrische Nephrologie. Pediatr Nephrol. 2000; 14(10-11):1016-21. DOI: 10.1007/s004670050065. View

3.
Farrer J, Rajfer J . Silicate urolithiasis. J Urol. 1984; 132(4):739-40. DOI: 10.1016/s0022-5347(17)49850-8. View

4.
Lee M, Lee Y, Hsu T, Chen M, Chang L . Silica stone--development due to long time oral trisilicate intake. Scand J Urol Nephrol. 1993; 27(2):267-9. DOI: 10.3109/00365599309181263. View

5.
Augusti M, Mikaelian J, Monsaint H, Brin D, Daudon M . [A silica urinary calculus secondary to the absorption of gelopectose in a child]. Prog Urol. 1993; 3(5):812-5. View